Jolly Jasleen K, Groppe Markus, Birks Jacqueline, Downes Susan M, MacLaren Robert E
Nuffield Laboratory of Ophthalmology, University of Oxford, Oxford, United Kingdom; Oxford Biomedical Research Centre and Moorfields Eye Hospital-UCL Institute of Ophthalmology NIHR Biomedical Research Centre, London, United Kingdom.
Nuffield Laboratory of Ophthalmology, University of Oxford, Oxford, United Kingdom; Oxford Biomedical Research Centre and Moorfields Eye Hospital-UCL Institute of Ophthalmology NIHR Biomedical Research Centre, London, United Kingdom.
Am J Ophthalmol. 2015 Oct;160(4):822-31.e3. doi: 10.1016/j.ajo.2015.06.018. Epub 2015 Jun 29.
To characterize defects in color vision in patients with choroideremia.
Prospective cohort study.
Thirty patients with choroideremia (41 eyes) and 10 age-matched male controls (19 eyes) with visual acuity of ≥6/36 attending outpatient clinics in Oxford Eye Hospital underwent color vision testing with the Farnsworth-Munsell 100 hue test, visual acuity testing, and autofluorescence imaging. To exclude changes caused by degeneration of the fovea, a subgroup of 14 patients with a visual acuity ≥6/6 was analyzed. Calculated color vision total error scores were compared between the groups and related to a range of factors using a random-effects model.
Mean color vision total error scores were 120 (95% confidence interval [CI] 92, 156) in the ≥6/6 choroideremia group, 206 (95% CI 161, 266) in the <6/6 visual acuity choroideremia group, and 47 (95% CI 32, 69) in the control group. Covariate analysis showed a significant difference in color vision total error score between the groups (P < .001 between each group).
Patients with choroideremia have a functional defect in color vision compared with age-matched controls. The color vision defect deteriorates as the degeneration encroaches on the fovea. The presence of an early functional defect in color vision provides a useful biomarker against which to assess successful gene transfer in gene therapy trials.
描述脉络膜视网膜炎患者的色觉缺陷。
前瞻性队列研究。
牛津眼科医院门诊中30例脉络膜视网膜炎患者(41只眼)和10名年龄匹配的男性对照者(19只眼),视力≥6/36,接受了 Farnsworth-Munsell 100色调测试、视力测试和自发荧光成像的色觉测试。为排除中央凹变性引起的变化,分析了14例视力≥6/6的患者亚组。使用随机效应模型比较各组计算出的色觉总误差分数,并将其与一系列因素相关联。
视力≥6/6的脉络膜视网膜炎组的平均色觉总误差分数为120(95%置信区间[CI] 92, 156),视力<6/6的脉络膜视网膜炎组为206(95% CI 161, 266),对照组为47(95% CI 32, 69)。协变量分析显示各组之间色觉总误差分数存在显著差异(每组之间P <.001)。
与年龄匹配的对照组相比,脉络膜视网膜炎患者存在色觉功能缺陷。随着变性侵犯中央凹,色觉缺陷会恶化。色觉早期功能缺陷的存在为基因治疗试验中评估成功的基因转移提供了一种有用的生物标志物。